Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Post S et al. - In a study to assess whether expression of topoisomerase I (Topo I) and thymidylate synthase (TS) helps predict treatment response in pts undergoing irinotecan and capecitabine-based chemoradiation, it was reported that Topo I expression in rectal tumour mucosa might serve as a predictor of response to neoadjuvant irinotecan-based chemoradiation, and might be a factor contributing to development of individualized treatment.

Methods

Results

Related Articles

Obesity linked to specific cancers
Internet Source, 11/05/09    Relevance Score: 69%

Plasma enterolactone and risk of colon and rectal cancer in a case–cohort study of Danish men and women
Cancer Causes and Control, 10/28/09    Relevance Score: 69%

Childhood Cancer Survivors Experience Suicidal Thoughts Decades After Diagnosis
ScienceDaily, 10/27/09    Relevance Score: 69%

American Cancer Society Stands by Cancer Screening Guidelines
MedLinePlus, 10/23/09    Relevance Score: 69%

New Drug Aims To Seek And Destroy Many Types Of Cancer
ScienceDaily, 10/07/09    Relevance Score: 69%

Today in Basic Science/Genetics...keeping you current

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Proceedings of the National Academy of Sciences of the United States of America, 12/09/09

A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy
Breast Cancer Research and Treatment, 12/09/09

Expression of Hiwi in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis
BMC Cancer, 12/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address